GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Item 9 Labs INLB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Item 9 Labs

Our reporting

We have not reported on Item 9 Labs yet.

Next results

2 Dec 2026

Due on 2 Dec 2026. Analysts expect earnings of -0.04 a share on revenue of $6.5m.

Past results

Reported against what analysts expected

20 Aug 202323 May 202314 Feb 202313 Jan 202315 Aug 202216 May 2022
Earnings per share-0.06-0.03-0.03-0.20-0.06-0.04
Forecast-0.03-0.04-0.05-0.04-0.03-0.03
Revenue$5.0m$5.7m$5.0m$4.0m$4.9m$6.6m
Forecast$6.0m$5.5m$5.5m$4.0m$7.0m$7.3m

Key events

  1. 18 Oct 201820-to-1 reverse split
  2. 3 Jan 20123-for-1 share split
  3. 3 Nov 2011Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.